CSIMarket


Abbvie Inc.  (ABBV)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Abbvie Inc.

ABBV's Fundamental analysis






Abbvie's sales fell by -0.28 % in II. Quarter 2019 from the same quarter a year ago. Ranking at No. 2461

Biotechnology & Drugs industry recorded growth of revenues by 0.68 %

Abbvie's net profit deacreased by -62.63 % in II. Quarter 2019 year on year, to $741 millions.

More on ABBV's Growth


Abbvie
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Company is currently trading with Price to Cash flow multiple of 86.72 in trailing twelve-month period.
Company
34.74
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 4.32.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.87.


More on ABBV's Valuation
 
 Total Debt (Millions $) 37,260
 Dividend TTM ($) 4.08 $
 Dividend Yield TTM (%) 4.52 %
 Revenue/Employee (TTM) $ 1,254,769
 Net Income/Employee (TTM) $ 158,385
 Receivable Turnover (TTM) 5.85
 Tangible Book Value (Per Share $) -30.10

Abbvie
current PE on trailing twelve month basis is above Biotechnology & Drugs industry average.

Company is currently trading with Price to Cash flow multiple of 86.72 in trailing twelve-month period.
Company
34.74
PE TTM   
Industry
0
PE TTM    
Company's Price to Sales ratio is at 4.32.
Biotechnology & Drugs industry's Price to Sales ratio is at 4.87.


More on ABBV's Valuation

 Market Capitalization (Millions $) 140,921
 Shares Outstanding (Millions) 1,484
 Employees 26,000
 Revenues (TTM) (Millions $) 32,624
 Net Income (TTM) (Millions $) 4,118
 Cash Flow (TTM) (Millions $) 1,625
 Capital Exp. (TTM) (Millions $) -640
 Total Debt (Millions $) 37,260
 Dividend TTM ($) 4.08 $
 Dividend Yield TTM (%) 4.52 %
 Revenue/Employee (TTM) $ 1,254,769
 Net Income/Employee (TTM) $ 158,385
 Receivable Turnover Ratio (TTM) 5.85
 Tangible Book Value (Per Share $) -30.10

 Market Capitalization (Millions $) 140,921
 Shares Outstanding (Millions) 1,484
 Employees 26,000
 Revenues (TTM) (Millions $) 32,624
 Net Income (TTM) (Millions $) 4,118
 Cash Flow (TTM) (Millions $) 1,625
 Capital Exp. (TTM) (Millions $) -640

ABBV's Profitability Comparisons
Abbvie achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2019 to 41.19 % from 38.45 % in I. Quarter.

Abbvie net profit margin of 8.98 % is currently ranking no. 17 in Biotechnology & Drugs industry, ranking no. 115 in Healthcare sector and number 1541 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 0.89
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.54
  Inventory Turnover Ratio (TTM) 4.22



Abbvie achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in II. Quarter 2019 to 41.19 % from 38.45 % in I. Quarter.

Abbvie net profit margin of 8.98 % is currently ranking no. 17 in Biotechnology & Drugs industry, ranking no. 115 in Healthcare sector and number 1541 in S&P 500.

More on ABBV's Key Ratios





             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MXIM's Profile

Stock Price

MXIM's Financials

Business Description

Fundamentals

Charts & Quotes

MXIM's News

Suppliers

MXIM's Competitors

Customers & Markets

Economic Indicators

MXIM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071